Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease pulmonary arterial hypertension
Comorbidity C0009782|connective tissue disease
Sentences 32
PubMedID- 23686514 Rapid progression to pulmonary arterial hypertension crisis associated with mixed connective tissue disease in an 11-year-old girl.
PubMedID- 20375662 Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease.
PubMedID- 21676917 The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
PubMedID- 22709477 Exercise training in pulmonary arterial hypertension associated with connective tissue diseases.
PubMedID- 23906950 pulmonary arterial hypertension associated with connective tissue disease: meta-analysis of clinical trials.
PubMedID- 20160534 pulmonary arterial hypertension in connective tissue diseases.
PubMedID- 25748129 [management of borderline pulmonary arterial hypertension associated with connective tissue diseases].
PubMedID- 23732415 Results: the most common connective tissue disease associated with pulmonary arterial hypertension was diffuse scleroderma in 46% of cases.
PubMedID- 26155616 [clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class iv) pulmonary arterial hypertension associated with diffuse connective tissue diseases].
PubMedID- 25076987 The second part, however, is more extensive and targets certain groups/diseases of ph, such as connective tissue disease associated with pulmonary arterial hypertension (ctd-apah), hemolytic anemia associated with ph, portopulmonary arterial hypertension, congenital heart diseases (chd)-apah, chronic thromboembolic pulmonary hypertension (cteph), and creating detailed review articles.
PubMedID- 19653056 Efficacy of bosentan in the treatment of a patient with mixed connective tissue disease complicated by pulmonary arterial hypertension.
PubMedID- 22137255 Methods: forty-eight patients (mean age, 41.3 +/- 11.6 years; 91.7% women) with pulmonary arterial hypertension associated with connective tissue diseases who underwent right-heart catheterization and acute pulmonary vasodilator testing were prospectively recruited.
PubMedID- 24822109 Objective: to investigate the prevalence of anti-endothelial cell antibodies (aeca) in connective tissue diseases (ctd) associated with pulmonary arterial hypertension (pah) and to corroborate the pathologic function of aeca in pah-associated ctds.
PubMedID- 21873802 Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease.
PubMedID- 22720870 ¶:p < 0.05 in comparison to group 2, pulmonary arterial hypertension associated with connective tissue disease (pah-ctd).
PubMedID- 25129118 [pulmonary arterial hypertension associated with connective tissue diseases].
PubMedID- 22015567 pulmonary arterial hypertension in connective tissue diseases.
PubMedID- 22621693 Treatment of pulmonary arterial hypertension in connective tissue disease.
PubMedID- 20449950 Prevalence of anti-endothelial cell antibodies in patients with pulmonary arterial hypertension associated with connective tissue diseases.
PubMedID- 25877137 [the more particular clinical classification of connective tissue diseases with pulmonary arterial hypertension, the more precise choice of therapy].
PubMedID- 20919946 Objectives: to describe the findings of cardiovascular magnetic resonance (cmr) imaging in patients with pulmonary arterial hypertension (pah) associated with connective tissue disease (ctd) and in consecutive patients with systemic sclerosis (ssc) without pah.
PubMedID- 25076994 Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: pulmonary arterial hypertension associated with connective tissue diseases.
PubMedID- 25214713 Effect of th17 and treg axis disorder on outcomes of pulmonary arterial hypertension in connective tissue diseases.
PubMedID- 22589263 Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease.
PubMedID- 21212140 Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases.
PubMedID- 22205898 Associated pulmonary arterial hypertension in connective tissue diseases.
PubMedID- 21963571 pulmonary arterial hypertension associated with connective tissue disease and immunosuppressive therapy.
PubMedID- 22748903 pulmonary arterial hypertension in connective tissue diseases.
PubMedID- 26022952 Patients with pulmonary arterial hypertension associated with connective tissue disease had significantly poorer survival rates compared to other aetiologies (p<0.003).the favourable short-term haemodynamic results and good survival rates, observed in patients receiving both bosentan and sildenafil, supports the use of sequential combination therapy in patients failing on monotherapy in a real-world setting.
PubMedID- 25818118 Associations between sildenafil use and changes in days of hospitalization in a population with pulmonary arterial hypertension associated with connective tissue disease.
PubMedID- 21418827 [the value of brain natriuretic peptide in connective tissue diseases associated with pulmonary arterial hypertension].
PubMedID- 23359006 Objective: to assess the efficacy of epoprostenol treatment in japanese patients with pulmonary arterial hypertension (pah) associated with connective tissue disease (ctd).

Page: 1